These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2360919)

  • 41. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?
    Sasahara M; Raines EW; Chait A; Carew TE; Steinberg D; Wahl PW; Ross R
    J Clin Invest; 1994 Jul; 94(1):155-64. PubMed ID: 8040256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of oxidized lipoproteins in the pathogenesis of atherosclerosis.
    Kita T; Yokode M; Ishii K; Kume N; Nagano Y; Arai H; Otani H; Ueda Y; Hara S
    Clin Exp Pharmacol Physiol Suppl; 1992; 20():37-42. PubMed ID: 1446408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Probucol does not affect lipoprotein metabolism in macrophages of Watanabe heritable hyperlipidemic rabbits.
    Nagano Y; Kita T; Yokode M; Ishii K; Kume N; Otani H; Arai H; Kawai C
    Arteriosclerosis; 1989; 9(4):453-61. PubMed ID: 2751475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Predisposition to in vitro oxidation of LDL isolated from hypercholesterolemic patients. Interaction with arterial proteoglycans].
    Barón L; López F
    Acta Cient Venez; 1999; 50(1):1-10. PubMed ID: 10513033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit.
    Naruszewicz M; Carew TE; Pittman RC; Witztum JL; Steinberg D
    J Lipid Res; 1984 Nov; 25(11):1206-13. PubMed ID: 6520542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sterol synthesis in vitro in freshly isolated blood mononuclear leukocytes from familial hypercholesterolemic patients treated with probucol.
    McNamara DJ; Bloch CA; Botha A; Mendelsohn D
    Biochim Biophys Acta; 1985 Mar; 833(3):412-6. PubMed ID: 3970963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of lipoprotein lipids, dietary fat and smoking on macrophage degradation of native and oxidized low density lipoprotein.
    Regnström J; Walldius G; Hådell K; Johansson J; Holme I; Olsson AG; Nilsson J
    Atherosclerosis; 1994 Sep; 110(1):13-23. PubMed ID: 7857366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pharmacology of probucol. I].
    Donatelli L
    Clin Ter; 1984 Mar; 108(5):367-88. PubMed ID: 6232074
    [No Abstract]   [Full Text] [Related]  

  • 49. Apolipoprotein oxidation in the absence of lipid peroxidation enhances LDL uptake by macrophages.
    Hunt JV; Bailey JR; Schultz DL; McKay AG; Mitchinson MJ
    FEBS Lett; 1994 Aug; 349(3):375-9. PubMed ID: 8050600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein. Use of a new water-soluble probucol derivative.
    Parthasarathy S
    J Clin Invest; 1992 May; 89(5):1618-21. PubMed ID: 1569200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification.
    Jialal I; Grundy SM
    J Clin Invest; 1991 Feb; 87(2):597-601. PubMed ID: 1991843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro activity of probucol on cholesteryl ester transport.
    Chiesa G; Franceschini G; Sirtori CR
    Biochim Biophys Acta; 1990 Aug; 1045(3):302-4. PubMed ID: 2386803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters.
    El-Swefy S; Schaefer EJ; Seman LJ; van Dongen D; Sevanian A; Smith DE; Ordovas JM; El-Sweidy M; Meydani M
    Atherosclerosis; 2000 Apr; 149(2):277-86. PubMed ID: 10729377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Probucol treatment in hypercholesterolemic patients: effects on lipoprotein composition, HDL particle size, and cholesteryl ester transfer.
    Bagdade JD; Kaufman D; Ritter MC; Subbaiah PV
    Atherosclerosis; 1990 Oct; 84(2-3):145-54. PubMed ID: 2282096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Probucol: a new cholesterol-lowering drug effective in patients with type II hyperlipoproteinemia.
    Salel AF; Zelis R; Sodhi HS; Price J; Mason DT
    Clin Pharmacol Ther; 1976 Dec; 20(6):690-4. PubMed ID: 186224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of biologically modified low-density lipoprotein in atherosclerosis.
    Carew TE
    Am J Cardiol; 1989 Oct; 64(13):18G-22G. PubMed ID: 2679026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia.
    Fellin R; Gasparotto A; Valerio G; Baiocchi MR; Padrini R; Lamon S; Vitale E; Baggio G; Crepaldi G
    Atherosclerosis; 1986 Jan; 59(1):47-56. PubMed ID: 3081013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Positive correlation between probucol in low density lipoprotein and LDL-lowering.
    Shinomiya M; Shirai K; Saito Y; Yoshida S
    Eur J Clin Pharmacol; 1993; 45(4):343-6. PubMed ID: 8299667
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profiles.
    Helve E; Tikkanen MJ
    Atherosclerosis; 1988 Aug; 72(2-3):189-97. PubMed ID: 3063268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gemfibrozil metabolite inhibits in vitro low-density lipoprotein (LDL) oxidation and diminishes cytotoxicity induced by oxidized LDL.
    Kawamura M; Miyazaki S; Teramoto T; Ashidate K; Thoda H; Ando N; Kaneko K
    Metabolism; 2000 Apr; 49(4):479-85. PubMed ID: 10778872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.